Agilon Health (AGL) Projected to Release Earnings on Wednesday

Agilon Health (NYSE:AGL) is anticipated to issue its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect the company to post earnings of $0.06 per share and revenue of $1.4503 billion for the quarter. Individuals can find conference call details on the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Wednesday, August 5, 2026 at 4:30 PM ET.

Agilon Health (NYSE:AGL) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.38 billion. On average, analysts expect Agilon Health to post $-4 EPS for the current fiscal year and $-3 EPS for the next fiscal year.

Agilon Health Trading Up 0.7%

Shares of Agilon Health stock opened at $99.16 on Wednesday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08. The stock has a fifty day simple moving average of $105.43 and a 200 day simple moving average of $52.23. Agilon Health has a 12-month low of $7.48 and a 12-month high of $133.04. The company has a market capitalization of $1.65 billion, a P/E ratio of -4.60 and a beta of 2.98.

Wall Street Analyst Weigh In

Several research firms recently weighed in on AGL. Jefferies Financial Group upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and increased their price target for the company from $27.50 to $48.00 in a research report on Thursday, May 7th. Wells Fargo & Company reiterated an “overweight” rating and issued a $141.00 target price (up from $72.00) on shares of Agilon Health in a research note on Monday, July 13th. JPMorgan Chase & Co. lowered shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price target for the company. in a research note on Monday, May 4th. Citigroup cut shares of Agilon Health from a “neutral” rating to a “sell” rating and lifted their price target for the stock from $80.00 to $105.00 in a report on Thursday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft raised Agilon Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $33.00 to $49.00 in a report on Thursday, May 7th. Five research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $66.50.

Institutional Trading of Agilon Health

Large investors have recently modified their holdings of the business. LPL Financial LLC grew its holdings in shares of Agilon Health by 213.4% during the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after purchasing an additional 30,000 shares in the last quarter. CIBC Bancorp USA Inc. purchased a new position in shares of Agilon Health in the 3rd quarter worth about $34,000. Focus Partners Advisor Solutions LLC purchased a new position in shares of Agilon Health in the 4th quarter worth about $53,000. Tower Research Capital LLC TRC increased its position in shares of Agilon Health by 214.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 37,079 shares of the company’s stock valued at $85,000 after purchasing an additional 25,270 shares during the last quarter. Finally, Mercer Global Advisors Inc. ADV purchased a new position in shares of Agilon Health during the 4th quarter valued at about $86,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.